Ann: Change in substantial holding, page-19

You are an absolute idiot. Read the presentation from the webinar. $5M up front and another $5M in June - no strings on that money. A further $4.7M subject to development stages over 24 months. $3.7M is paid on completion of the prototype.

Conducting CR at the price they did is frustrating however without the signed deal from Hologoic at the time, it was required to get Febridx and Viradx guaranteed to distributors.

To further point out your stupidity, CLIA waiver allows them to expand the channels in which they distribute. They are currently available to distribute to 10,000 labs. The waiver opens that up to 260,000 GP clinics etc.